(Q71104831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6643605%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Determination of canrenone, the major metabolite of spironolactone, in plasma and urine by high-performance liquid chromatography (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6643605%20AND%20SRC:MED&resulttype=core&format=json

high-performance liquid chromatography

16 October 2019

main subject

1 reference

W Krause

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6643605%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

J Karras

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6643605%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

U Jakobs

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6643605%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

publication date

1 October 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6643605%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6643605%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

191-199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6643605%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984836-7

7 January 2021

Blocking the renal electrolyte effects of mineralocorticoids with an orally active steroidal spirolactone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984836-7

7 January 2021

Isolation and identification of novel sulfur-containing metabolites of spironolactone (Aldactone®)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984836-7

7 January 2021

Isolation and identification of a sulfur-containing metabolite of spironolactone from human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984836-7

7 January 2021

Spironolactone. III. Canrenone—maximum and minimum steady‐state plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984836-7

7 January 2021

Pharmacokinetic and Metabolic Fate of Potassium Canrenoate (SC-14266) in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984836-7

7 January 2021

Fluorometric Microassay for Spironolactone and Its Metabolites in Biological Fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984836-7

7 January 2021

Simultaneous automated determination of spironolactone metabolites in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984836-7

7 January 2021

Spironolactone and potassium canrenoate in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984836-7

7 January 2021

High-performance liquid chromatographic determination of canrenone, a major metabolite of spironolactone, in body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984836-7

7 January 2021

Determination of plasma levels of spirorenone, a new aldosterone antagonist, and one of its metabolites by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2984836-7

7 January 2021

10.1016/S0378-4347(00)84836-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6643605%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference